(精编)DIABETIC DYSLIPIDEMIA or Diabetes Lipidus教学课件.ppt

ACE Inhibitors : Evidence of benefit in diabetic subjects 1- Renoprotective : MICRO-HOPE = Ramipril showed a statistically significant benefit over placebo in preventing the progression from microalbuminuria to overt nephropathy. UKPDS = Did not show such a benefit when comparing Captopril to Atenolol ACE Inhibitors : Evidence of benefit in diabetic subjects 2 - cardiovascular protection : MICRO-HOPE = Ramipril vs placebo CAPPP Study = Captopril vs Diuretics or Beta blocker ABCD Study =